Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms-Reference-Cited by-同舟云学术

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms

Published:2014-05-02 Issue:9 Volume:5 Page:2349-2354
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wheler Jennifer J.¹,Parker Barbara A.²,Lee Jack J.³,Atkins Johnique T.¹,Janku Filip¹,Tsimberidou Apostolia M.¹,Zinner Ralph¹,Subbiah Vivek¹,Fu Siqing¹,Schwab Richard²,Moulder Stacy⁴,Valero Vicente⁴,Schwaederle Maria⁵,Yelensky Roman⁶,Miller Vincent A.⁶,Stephens M Philip J.⁶,Meric-Bernstam Funda¹,Kurzrock Razelle²

Affiliation:

1. Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX

2. Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California at San Diego Moores Cancer Center

3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

4. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

5. Center for Personalized Cancer Therapy, Moores Cancer Center, University of California San Diego, La Jolla, CA

6. Foundation Medicine, Cambridge MA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II trial of fulvestrant plus enzalutamide in ER+/HER2− advanced breast cancer;npj Breast Cancer;2023-05-20

2. RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples;Frontiers in Oncology;2021-09-28

3. Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling;Advances in Biological Regulation;2020-12

4. A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer;International Journal of Molecular Sciences;2020-07-08

5. Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients;International Journal of Cancer;2020-06